Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 29, 2012
Grant Date -
Aug 18, 2005
app pub date -
Dec 17, 2004
filing date -
Dec 31, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
One aspect of the current invention is a method of preventing and/or treating arthritis and/or preventing or treating lameness in a subject. Additionally, subject quality of life and welfare, and body condition scores are improved by utilizing methodology that administers the nucleic acid expression construct encoding a GHRH or functional biological equivalent to a subject through a parenteral route of administration. Following a single dose of nucleic acid expression vector, subjects are healthier and effects are demonstrated long term without additional administration(s) of the expression construct.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully